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The human immunodeficiency virus-1 (HIV-1) Nef protein, orig-
inally identified as a negative factor, has now emerged as one of the
most important viral proteins necessary for viral pathogenesis and
disease progression. Nef has been also implicated in viral infectivity
and replication, however, themolecularmechanismofNef-induced
viral gene expression and replication is not clearly understood.
Although involvement of heat shock proteins in viral pathogenesis
has been reported earlier, a clear understanding of their role
remains to be elucidated. Here we report for the first time that Nef
not only interacts with heat shock protein 40 (Hsp40) but it also
induces the expression of Hsp40 in HIV-1-infected cells. The inter-
action between Nef and Hsp40 is important for increased Hsp40
translocation into the nucleus of infected cells, which seems to facil-
itate viral gene expression by becoming part of the cyclin-depend-
ent kinase 9-associated transcription complex regulating long ter-
minal repeat-mediated gene expression. The finding is consistent
with the failure of thenef-deleted virus to induceHsp40, resulting in
reduced virus production. Our data further shows that, whereas,
Hsp40 overexpression induces viral gene expression, silencing of
Hsp40 reduces the gene expression in a Nef-dependent manner.
Thus our results clearly indicate that Hsp40 is crucial for Nef-me-
diated enhancement of viral gene expression and replication.
Viruses are known to modulate cellular proteins for successful repli-
cationwithin the host cells. The sequence of events in the establishment
of a productive infection by human immunodeficiency virus type 1
(HIV-1)3 not only involves interaction between a number of viral and
cellular factors but is also accompanied by complex and dynamic
changes in the patterns of cellular gene expression. Nef, a 27–30-kDa
myristoylated phosphoprotein, encoded by HIV-1 has been shown to
play a crucial role in viral pathogenesis by modulating cellular gene
expression and signaling pathways (1, 2). nef-deleted viruses fail to rep-
licate efficiently in vivo, and do not develop symptoms of acquired
immunodeficiency syndrome (AIDS) (3, 4). Nef is also thought to con-
tribute to viral pathogenesis by down-regulation of CD4 and major his-
tocompatibility complex class I surface molecules preventing viral
superinfection and by helping the virus to evade host immune system.
Nef has also been implicated in the activation of T cells, making the cells
permissible to the virus (5, 6). All these functions of Nef are manifested
by a number of important events such as activation of upstream signal-
ingmolecules, inhibition of apoptosis in the infected cell, activation and
up-regulation of transcription factors, alleviation of repressors of tran-
scription, as well as increase of the infectivity of newly produced virions
(1, 7). Even though these functions of Nef have been well studied, con-
troversy exists on its role in viral infectivity and replication as both
negative (8, 9) and positive (10, 11) effects are available in the literature.
Although a number of reports show that Nef increases viral replication
by activating T cells, the molecular basis of Nef-induced viral gene
expression and replication remains to be clearly elucidated.
Cellular heat shock proteins (Hsp) are chaperone molecules known
to participate in protein folding, transport, and assembly. Hsps are
induced in cells during stress conditions like heat shock, UV irradiation,
and even microbial/viral infections (12, 13). Recent studies have
revealed that Hsps are also involved in apoptosis and immune response
(14, 15). In mammalian cells, expression of a number of Hsps, including
Hsp40, Hsp70, Hsp90, and Hsp100, is enhanced by heat shock and reg-
ulated at the transcriptional level (16). Hsp40, a heat-inducible DnaJ
homologue, has been found to co-localize with Hsp70 (17, 18) and
assists Hsp70 in folding of nascent proteins (19–21). The major func-
tion of Hsp40 is to regulate the ATP-dependent polypeptide binding by
Hsp70 (19, 22). Among all the heat shock proteins studied to date,
Hsp70 has been shown to play an important role in the HIV-1 life cycle.
Hsp70 is overexpressed in lymphocytes of HIV-positive individuals and
is also found abundantly in HIV virions (23, 24). Hsp70 and Hsp90 have
been shown to stabilize the assembly of the active cdk9-cyclin T1 com-
plex responsible for positive transcription elongation factor b (P-TEFb)
or Tat-associated kinase complex-mediated Tat transactivation (25).
However, the role of Hsp40 in the HIV life cycle remains to be studied.
Nefwas previously reported as a negative factor for viral replication in
T cell lines (26), but recent reports demonstrated Nef as an enhancer of
viral replication (27–31). However, the molecular mechanism of this
positive effect needs to be clearly elucidated. It is well known that Nef
performs most of its functions by interacting with different proteins (1,
7). Although the functions attributed to Nef remain conserved across
different HIV-1 subtypes, most of the functional studies for Nef to date
have been performed with subtype B Nef protein. There is scant litera-
ture regarding subtype C Nef, the most prevalent subtype in the world.
In the reported study, we have attempted to identify novel Nef interact-
ing host cell factors using subtype C Nef as bait in the yeast two-hybrid
system. Our results showed that both subtype C and subtype B Nef
interacted with a human DnaJ homologue, Hsp40, in vitro and in vivo.
This interaction led to increased viral gene expression and virus pro-
duction. Furthermore, Hsp40 expression was increased in HIV-1-in-
fected cells in a Nef-dependent manner and this up-regulation was nec-
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essary for increased viral replication. Finally, Hsp40 seems to form part
of the cdk9-associated transcription complex that regulates viral gene
expression; an observation that provides a molecular basis for Nef-me-
diated enhancement of viral gene expression and replication.
EXPERIMENTAL PROCEDURES
Plasmids, Cell Lines, and Antibodies—The nef gene fromHIV-1 sub-
type C Indian isolate IN301904 (32) was amplified by PCR using the
following primers: subtype C Nef, forward, 5-GAGGATCCCGAT-
GGGGGGCAAG-3; and reverse, 5-CGGAATTCGCATGTCAG-
CAGTC-3. This PCRproductwas first cloned into pGEMTEasy vector
(Promega) according to themanufacturer’s instructions. The subtype C
Nef fragment was taken from pGEMT Easy-NefC and cloned into the
BamHI and EcoRI sites of pCDNA3.1 (Invitrogen). The pAS2–1NefC
expression vector was constructed by cloning subtype C Nef from
pGEMT Easy-NefC into BamHI and SalI sites of pAS2-1 (Clontech).
The sequence of cloned nef was confirmed by DNA sequencing (ABI
310 Genetic Analyzer, ABI). Expression of Nef from both vectors was
confirmed by immunoblotting. The pAS2–1NefC plasmid expresses
subtypeCNef andGal4DNAbinding domain as a fusion protein, which
was used as the bait protein in yeast two-hybrid library screening. A
cDNA library of human leukocytes in the pACT2 vector was obtained
from Clontech. pCDNA-Hsp40, pCDNA3 expressing human Hsp40,
was a kind gift of Dr. Margarida D. Amaral (33). NL4-3 Nef cloned in
pCDNA (pCDNA-Nef) and NL4-3 Nef tagged with HA (HA-Nef) plas-
mids were kind gifts of Dr. M. Federico and Dr. W. C. Greene, respec-
tively. The NL4-3 molecular clone (pNL4-3) was obtained from the
National Institutes of Health AIDS repository (34). The nef-deleted
NL4-3 molecular clone (pNL4–3Nef) and glutathione S-transferase
(GST)-Nef plasmids were obtained from Dr. K. Saksela. 293T cells
(human embryonic kidney cell line) were obtained from the NCCS Cell
Repository, India. CEM-GFP, a CD4 human T cell line, was obtained
from the National Institutes of Health AIDS repository (35). Mono-
clonal and polyclonal Nef antibodies were obtained from the National
Institutes of Health AIDS repository (36, 37). Antibodies against Hsp40,
Hsp70, Hsp90, cdk9, and rabbit anti-HA antibody were obtained from
Santa Cruz Biotechnology.
Yeast Two-hybrid Assay—A human leukocyte cDNA library in
pACT2 vector (Clontech) was screened for Nef interacting proteins by
co-transformation with the pAS2–1NefC bait plasmid into yeast strain
AH109 (Clontech). Positive clones were selected based on growth in
medium lacking adenine, histidine, tryptophan, and leucine and also by
expression of -galactosidase, which gives a blue color on plates con-
taining X-gal. Co-transformants in AH109 yeast strains were screened
three times for growth on these selection plates and also for -galacto-
sidase activity on plates to exclude false positive clones. Liquid -galac-
tosidase assay was finally performed to confirm the interaction, using
the yeast -galactosidase assay kit from Pierce, as per the manufactur-
er’s protocol. The interacting protein in the positive clonewas identified
by rescuing the gene fragment, using PCR amplification with pACT2-
specific primers followed by DNA sequencing.
Transient Transfection and Luciferase Assay—HEK-293T cells were
transfected with LTR-reporter vector (pLTR-Luc) along with other
expression vectors using calcium phosphate precipitation and har-
vested 36 h post-transfection for luciferase assay. After 4 h of transfec-
tion, the transfected cells were either treated or mock treated with HSP
inhibitor KNK437 (Calbiochem) at 100M final concentration for 32 h.
The cells were then lysed in cell lysis reagent (Promega), and luciferase
assays were performed using Luclite substrate (PerkinElmer Life Sci-
ences). Normalization of transfection efficiency was done using the
enhanced green fluorescent protein reporter (pEGFP-N1) co-transfec-
tion and quantitation as described earlier (38). The culture supernatants
were also collected at the time of luciferase assay fromHIV-1NL4-3 and
the nef-deleted NL4-3 molecular clone-transfected cells to determine
virus production.
HIV-1 Infection and Virus Quantitation—5  106 CEM-GFP cells
were infectedwithHIV-1NL4-3 virus at amultiplicity of infection of 0.1
in the presence of Polybrene (1g/ml) as described earlier (39). Periph-
eral blood was collected from normal seronegative donors and PBMCs
were isolated by Ficoll-Hypaque (AmershamBiosciences) gradient cen-
trifugation. Cells were activated with 5 g/ml phytohemagglutinin
(Sigma) for 36–48 h. 5  106 activated PBMCs were infected with 0.5
multiplicity of infection of NL4-3 virus for 4 h in the presence of Poly-
brene (1g/ml) with intermittentmixing as described earlier (39). After
washing, the cells were plated in Complete medium supplemented with
human interleukin-2 (Roche Applied Bioscience) at 20 units/ml con-
centrations and incubated at 37 °C in a humidified CO2 incubator. The
culture supernatants from infected and molecular clone-transfected
cells were used to determine virus production by p24gag antigen capture
ELISA (PerkinElmer Life Sciences).
Immunoprecipitation, GST Pull-down, and Immunoblotting—Re-
combinant [35S]methionine-labeled Nef and Hsp40 proteins were syn-
thesized from pCDNA-NefC and pCDNA-Hsp40 plasmids using the
coupled in vitro transcription and translation kit as per themanufactur-
er’s instructions (Promega). These proteins were incubated together in
binding buffer (20mMHEPES, pH7.4, 1mMdithiothreitol, 2mMMgCl2,
100 g/ml bovine serum albumin) and were then immunoprecipitated
with polyclonal antibody against Nef. The antigen-antibody complex
was pulled down by an equal mixture of protein A- and protein G-aga-
rose beads and resolved on 12% SDS-PAGE. The gel was then prepared
for fluorography as described elsewhere (40) and exposed to x-ray film
(Kodak).
Escherichia coli BL21(DE3) cells expressing either GST or GST-Nef
were induced with isopropyl -D-thiogalactoside followed by purifica-
tion of proteins using glutathione-Sepharose beads (Amersham Bio-
sciences). Transfected 293T cells overexpressing Hsp40 were lysed in
radioimmunoprecipitation assay (RIPA) buffer (20 mM Tris-HCl, pH
7.2, 0.15 M NaCl, 1% Triton X-100, 0.15% SDS, and 1% sodium deoxy-
cholate) with a protease inhibitor mixture (Roche Applied Bioscience).
The clarified lysates were incubated with either GST or GST-Nef pro-
tein immoblized on glutathione-Sepharose beads at 4 °C and subjected
to five washes with RIPA buffer. The complexes were resuspended in
Laemmli’s sample buffer, boiled, and resolved on 12% SDS-PAGE. Pro-
teins were transferred onto polyvinylidene difluoride membrane and
the membrane was probed with polyclonal Hsp40 antibody.
HEK-293T cells overexpressing HA-Nef and Hsp40 and CEM-GFP-
infected cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 5 mM
EDTA, 0.12 M NaCl, 0.5% Nonidet P-40, 0.5 mM NaF, 1 mM dithiothre-
itol, 0.5 mM phenylmethylsulfonyl fluoride) on ice for 45 min. Clarified
lysates were incubated with Hsp40 or Nef polyclonal antibody, and the
antigen-antibody complex was pulled down by an equal mixture of pro-
tein A- and protein G-agarose beads followed by resolution on 12%
non-reducing SDS-PAGE. The proteins were transferred onto polyvi-
nylidene difluoride membrane and the membrane was probed with
either HA antibody or Hsp40 antibody. The blots were developed by
using the ECL Plus system (Amersham Biosciences). Furthermore,
equal amounts of protein were taken from the CEM-GFP-infected cell
lysates or lysates from 293T cells transfectedwith viralmolecular clones
and were run on SDS-PAGE, followed by immunoblotting for Hsp40
and other proteins.
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Immunofluorescence Microscopy—HEK-293T cells grown on cover-
slips were transfected with both pCDNA-NefC and pCDNA-Hsp40 by
calcium phosphate precipitation. Cells were harvested 36 h post-trans-
fection and stained with polyclonal Hsp40 antibody and monoclonal
Nef antibody after fixing with 2% paraformaldehyde. The secondary
antibodies used for Hsp40 and Nef were indocarbocyanin (Cy3)-conju-
gated to anti-goat IgG (Chemicon) and fluorescein isothiocyanate-con-
jugated to anti-mouse IgG (Sigma), respectively. After washing, cells
were mounted in antifade on the slide, and the samples were analyzed
with a confocal microscope (Zeiss LSM 510, Germany).
Reverse Transcription-PCR—RNAwas prepared from 2 106 HIV-1
NL4-3-infected and uninfected PBMCs using TRIzol Reagent (Invitro-
gen). The cDNA was made using Moloney murine leukemia virus
reverse transcriptase (Invitrogen) followed by amplification by PCR for
HSP40 and human -ACTIN with Taq polymerase (Invitrogen) using
standard conditions and gene-specific oligonucleotide primers as
described: human -ACTIN: forward, 5-TGACGGGGTCACCCAC-
ACTGTGCCCATCTA-3, and reverse, 5-CTAGAAGCATTTGCG-
GTGGACGATGGAGGG-3; humanHSP40: forward, 5-CAGGATC-
CATGGTGGATTACTATGAAG-3, and reverse, 5-GTGGAAGA-
GAATGAAGTGAGG-3.
Quantification of HSP40 Expression by Real-time PCR—HSP40
expression level was analyzed by quantitative real-time PCR of cDNA in
a 25-l reaction mixture containing SYBR Green IQ supermix (Bio-
Rad) and 10 pmol concentration of each of the human -ACTIN and
HSP40 primer pairs listed above, using the Icycler IQ real-time thermal
cycler (Bio-Rad). The amplification was performed using one cycle of
95 °C for 2 min and 40 cycles of 94 °C for 1 min, 58 °C for 1 min, and
72 °C for 1 min followed by melt curve analysis. The changes in the
threshold cycle (CT) values were calculated by the equation CT 
CT,target  CT,input. The -fold difference was calculated as follows: -fold
difference 2(CT).
Preparation of Nuclear and Cytoplasmic Extracts—107 infected or
uninfected CEM-GFP cells were pelleted down and washed with ice-
cold phosphate-buffered saline. Cells were resuspended in 400 l of
ice-cold buffer A (10mMHEPES, pH7.9, 10mMKCl, 1mMEDTA, 1mM
EGTA, 1 mM dithiothreitol, 0.1 mM p-aminobenzoic acid, 1 mM phen-
ylmethylsulfonyl fluoride, 10 g/ml leupeptin, 1 g/ml pepstatin, 50
g/ml aprotinin) and kept on ice for 15 min to allow the cells to swell.
After that 25l of 10%Nonidet P-40was added to the cells and vortexed
for 10 s. Then samples were centrifuged at 4 °C for 30 s to remove the
cytoplasmic fraction. The nuclear fraction was prepared by resuspend-
ing the remaining pellet in 200 l of ice-cold buffer C (20 mM HEPES,
pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol,
0.1 mM p-aminobenzoic acid, 1 mM phenylmethylsulfonyl fluoride, 10
g/ml leupeptin, 1g/ml pepstatin, 50g/ml aprotinin) and kept on ice
FIGURE 1. Amino acid homology between sub-
type C Nef and NL4-3 Nef. The amino acid align-
ment of subtype C Nef used in the present work
(Indian isolate 301904) and subtype B NL4-3 Nef
shows about 76% identity.
FIGURE 2. HIV-1 subtype C Nef physically inter-
acts with Hsp40 protein. A, Nef interacts with
Hsp40 in the yeast two-hybrid assay. A human leu-
kocyte cDNA librarywas screenedusing subtypeC
Nef as bait in the yeast two-hybrid system. One of
the clones co-expressing Hsp40 and Nef was
found positive after repeated screening. Liquid
-galactosidase activity assay was performed
using lysates from yeast co-transformants as
described under “Materials and Methods.” Lane 1,
pAS2.1 subtypeCNef andpACT2; lane 2, pTD1 and
pLAM5; lane 3, pTD1 and pVA3; lane 4, the identi-
fiedHsp40clone; lane5, pCL1, the full-lengthGAL4
plasmid transformant. B, Nef interacts with Hsp40
in vitro. Recombinant [35S]methionine-labeledNef
and Hsp40 proteins were synthesized using the in
vitro transcription and translation kit as described
in text. The two proteins were incubated together
followed by immunoprecipitation with Nef anti-
body. C, co-localization of Hsp40 and subtype C
Nef in co-transfected 293T cells. 293T cells were
grown on coverslips and transfected with
pCDNA-NefC and pCDNA-Hsp40. After 36 h, trans-
fected cells were stained with monoclonal Nef
antibody and polyclonal Hsp40 antibody as
described in the text. The indirect immunofluores-
cence was visualized by confocal microscopy.
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for 20 min. Equal amounts of nuclear and cytoplasmic extracts from
both infected and uninfected CEM-GFP cells were used for immuno-
blotting of Hsp40, Nef, RNA pol II, and actin as described above.
HSP40 Gene Silencing Using SiRNA—293T cells were transfected
with 100 nM control siRNA duplex made against the non-target gene or
SMARTpool siRNA duplexes made against HSP40 (Dharmacon) using
Lipofectamine 2000 reagent according to the manufacturer’s instruc-
tion (Invitrogen). After 24 h of siRNA transfection pNL4-3 or pNL4-
3Nef vectors were transfected using Lipofectamine 2000 reagent
according to manufacturer’s instructions (Invitrogen). After 72 h of
siRNA transfection, supernatant was collected, and virus production
was determined by p24gag antigen capture ELISA (PerkinElmer Life Sci-
ences). RNA was also isolated from these 293T cells and expression of
HSP40 and p24gagwas analyzed by RT-PCRusing gene-specific primers.
RESULTS
HIV-1 Nef protein interacts with a large number of cellular proteins,
most of which perform critical functions in signaling pathways.
Although Nef-mediated signaling has been well studied, however, the
molecular mechanism of Nef-mediated transcriptional enhancement
remains to be clearly elucidated. Furthermore, themajority of studies to
date have been performed with Nef protein from subtype B, so we ini-
tiated studies with subtype C Nef, which is not only the most prevalent
subtype in Africa and Asia but currently accounts for almost 50% of
infections worldwide. Although the majority of the functional domains
of Nef are well conserved across the subtype, considerable sequence
differences are observed. The subtype C Nef from Indian isolate
IN301904 used in the present study has about 76% identity at the amino
acid level with Nef from the well studied subtype B isolate NL4-3,
whereas both proteins show almost 84% similarity in amino acid
sequence (Fig. 1). We initiated the present study with screening for
subtype C Nef interacting cellular proteins.
Identification of a Novel HIV-1 Subtype C Nef-interacting Protein—To
identify novel proteins interacting with subtype C Nef, we screened a
human leukocyte cDNA library using full-length subtype CNef as bait in a
yeast two-hybrid system. Repeated screening on X-gal containing dropout
plates led to the identification of a specific positive clone. The gene
expressed in this clone was amplified by PCR using the pACT2-specific
primers. Sequence analysis and data base comparisons revealed that this
clone expressed a gene encoding for a human DnaJ homologue that is
HSP40. To further confirm this interaction, liquid -galactosidase assay
was performed as described under “Materials and Methods.” The yeast
clone expressingHsp40 and subtype CNef clearly showed-galactosidase
activity in liquid -galactosidase assay, confirming the protein-protein
interaction in the yeast system (Fig. 2A).
Subtype CNef Interacts with Hsp40—Recombinant [35S]methionine-
labeled subtype C Nef and Hsp40 protein were prepared from
pCDNA-NefC and pCDNA-Hsp40 plasmids, respectively, using in vitro
transcription and translations as described earlier. These two proteins
were then incubated together and immunoprecipitationwas carried out
with anti-Nef antibody. Fig. 2B clearly showed that subtype C Nef and
Hsp40 proteins interacted with each other in vitro as both the proteins
were present in lane 2, where Nef antibody was used for immunopre-
cipitation in contrast to no detectable band in immunoprecipitation
performed with control IgG. Whereas the larger Nef (27 kDa) is the
full-length Nef protein, the smaller Nef (25 kDa) corresponds to the
Nef protein synthesized as a result of translation initiation from an
internal methionine start site (30). This result further confirms that Nef
and Hsp40 interact with each other in vitro.
Hsp40 has been reported to be localized predominantly in the cyto-
plasm before heat shock and to relocalize in the nucleus after heat shock
(18, 41, 42), whereas Nef has been reported to be a predominantly cyto-
plasmic protein but has also been shown to be in the nucleus of HIV-1-
infected and transfected cells (36, 43, 44). As these proteins are reported
to be present both as cytoplasmic and nuclear proteins during different
cellular conditions, it would be interesting to know if these two proteins
co-localize. Therefore, we performed immunofluorescence staining for
both Hsp40 and Nef in co-transfected 293T cells as detailed under
“Materials and Methods.” As shown in Fig. 2C, confocal microscopic
images of immunostained cells clearly indicated that both proteins were
co-localized in the cytoplasm of transfected 293T cells. Co-localization
was further confirmed by Z-stack analysis of confocal images (data not
shown), which could probably be explained by predominantly cytoplas-
mic localization of both proteins in the normal cellular environment.
We then tested whether this interaction was specific for subtype C Nef
or whether this interaction can also be observed with subtype B Nef, for
which we have used Nef from a common laboratory derived subtype B
isolate, NL4-3.
NL4-3 Nef Also Interacts with Hsp40 Both in Vitro and in Vivo—To
test whether Hsp40 interacts with NL4-3 Nef, purified GST and GST-
FIGURE 3. Hsp40 physically interacts with subtype B NL4-3 Nef both in vitro and in
vivo. A, GST-Nef pulls down Hsp40 from Hsp40-transfected 293T cell lysate. GST (lane 1)
and GST-Nef beads (lane 2) were incubated with 293T cells lysate overexpressing Hsp40
followed by SDS-PAGE and immunoblotting (IB) with Hsp40 antibody. The Hsp40-trans-
fected 293T cell lysates (lane 3) were run in parallel as control. B, Hsp40 and Nef co-
immunoprecipitates from the transfected cell lysate. 293T cells were transfected with
the HA-NL4-3 Nef expression vector alone or with Hsp40 expression vector. After 48 h,
the cells were lysed, immunoprecipitated with anti-Hsp40 antibody (lane 2 and 3), and
followed by immunoblotting with anti-HA antibody as indicated in the figure. C, Nef
co-immunoprecipitateswithHsp40 inHIV-1-infectedCEM-GFP cell lysate. CEM-GFP cells
were infected with HIV-1 NL4-3 virus as described in text. The cells were lysed on day 7
post-infection. The lysates of uninfected CEM-GFP cells (lane 2) and infected CEM-GFP
cells (lane 3)were immunoprecipitatedwith anti-Nef antibody followedby immunoblot-
ting with anti-Hsp40 antibody.
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Nef were immobilized on glutathione-Sepharose beads and used to
pulldown Hsp40 from Hsp40 overexpressing 293T cell lysates. We
observed that the Hsp40 protein was specifically pulled down by GST-
Nef, whereas GST alone could not bring down Hsp40 (Fig. 3A).
To confirm this interaction in vivo, we performed co-immunopre-
cipitation from 293T cells expressing both Hsp40 and HA-Nef. The
immunoprecipitation was done with Hsp40 antibody followed by
immunoblotting with polyclonal HA antibody. The Nef protein co-im-
munoprecipitated with Hsp40 (lane 3) in cells expressing both proteins
(Fig. 3B). Similar co-immunoprecipitation experiments with anti-Nef
antibody from the lysates of uninfected or HIV-1 NL4-3 virus-infected
CEM-GFP cells also immunoprecipitated Hsp40 only from infected
CEM-GFP cell lysate but not from uninfected cell lysate (Fig. 3C). Thus
bothHsp40 andNef physically interact inHIV-1-infected cells and exist
in a complex.
Hsp40 Is Induced in HIV-1-infected Cells—Although modulation of
some cellular heat shock proteins is reported in HIV-1 infection, Hsp40
modulation was not reported earlier. Several studies reported increased
expression of Hsp70 in HIV-1 infection and showed its presence in the
virion (23, 24, 45). Therefore, we assessed the Hsp40 expression level in
HIV-1-infected CEM-GFP cells by immunoblotting for Hsp40. The
result showed that there was up-regulation of Hsp40 protein in HIV-1-
infected CEM-GFP cells (Fig. 4A). Because the Hsp40 expression level
increased in the infected CEM-GFP cell line, we performed RT-PCR for
Hsp40 with RNA prepared from HIV-1 NL4-3 infected (days 6 and 11
post-infection) and uninfected human PBMCs. As shown in Fig. 4B,
Hsp40 expression was induced in HIV-1-infected PBMCs. Taken
together, these data clearly indicate Hsp40 up-regulation in HIV-1-in-
fected cells.
Nef Is Required for Up-regulation of Hsp40 in HIV-1-infected Cells—
Because Nef interacts with Hsp40 in HIV-1-infected cells, we tested
whetherNef plays any role inHsp40 up-regulation inHIV-1-infected cells.
We analyzed Hsp40 expression in 293T cells transfected with either the
wild type NL4-3 molecular clone or nef-deleted NL4-3 or pCDNA-Nef
along with theNef-deleted molecular clone. A quantitative RT-PCR using
real-time PCR showed about a 2-fold increase in HSP40 transcription in
293T cells transfected with wild type molecular clone, but not in the cells
transfectedwithnef-deletedmolecularclone (Fig. 4C).Moreover,whenNef
was transfected in trans alongwith the nef-deletedmolecular clone,HSP40
expression was restored. Furthermore, an exactly similar profile of Hsp40
expression was observed at the protein level by immunoblotting of protein
lysates from transfected cells (Fig. 4D). These results clearly indicate that
HIV-1 up-regulates Hsp40 expression in a Nef-dependent manner.
Hsp40EnhancesHIV-1 LTR-drivenGene Expression in the Presence of
Nef—Because previous studies have shown that Hsp70 associates with
P-TEFb complex (25) and Nef enhances viral gene expression (30), we
examined a possible role of Hsp40 in viral gene expression. Hsp40 co-
transfection in 293T cells with Tat andNef showed a definite increase in
HIV-1 LTR-driven viral gene expression as compared with Tat and Nef
or Tat alone (Fig. 5A). Hsp40 overexpression along with Tat and Nef
resulted in at least a 1.5-fold increase in LTR-mediated reporter gene
expression than that observed with Tat and Nef and more than a 2.5-
FIGURE 4. Hsp40 is up-regulated in HIV-1 infection, which is dependent on Nef expression. A, Hsp40 is up-regulated in HIV-1-infected CEM-GFP cells. HIV-1 NL4-3-infected
CEM-GFP cells were lysed on day 7 post-infection and equal amounts of protein from uninfected and infected cells were used for immunoblotting of Hsp40. B, Hsp40 expression is
up-regulated in HIV-1-infected human PBMCs. RNA was isolated from uninfected and NL4-3-infected PBMCs on days 6 and 11 post-infection followed by RT-PCR for HSP40 using
gene-specific primers, as listed under “Materials and Methods.” Human -ACTINwas used as an internal control. C, Nef is required for up-regulation of Hsp40 expression. 293T cells
were transfectedwith empty vector (lane 1), HIV-1NL4-3molecular clone (lane 2), andnef-deletedNL4-3molecular clone (lane 3) or pCDNA-Nef alongwith thenef-deletedNL4-3 (lane
4). After 36 h of transfection, RNA was isolated followed by real-time PCR for HSP40 expression using human -ACTIN as a control. D, Hsp40 expression is reduced in the absence of
Nef and reverts back in thepresenceofNef inNL4-3-transfected cells. 293T cells lysates from transfectionsmentioned inCwereprepared after 48hof transfection andequal amounts
of protein were used in immunoblotting (IB) for Hsp40. Actin was used as an equal loading control.
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fold increase over the Tat-induced gene expression. This increase in
LTR-mediated viral gene expression because of Hsp40 is specific to the
Nef protein as overexpression of Hsp40 in the presence of either Tat
alone or Tat andVpr together did not increase the reporter gene expres-
sion (Fig. 5A). Similar experiments with subtype C Tat and Nef along
with the subtype C LTR promoter-driven reporter has also shown iden-
FIGURE5.Hsp40specificallyenhancesHIV-1LTR-mediatedgeneexpression inpresenceofNef.A, Hsp40enhancesTat-inducedLTR-mediatedgeneexpression specifically in the
presence of Nef, which is inhibited by KNK437. 293T cells were transfected with various expression vectors along with the LTR-Luc reporter as indicated in the figure. After 4 h of
transfection, cells were either treated or not treated with the Hsp overexpression inhibitor KNK437 (100 M) for 32 h. Cells were then lysed and luciferase assay was performed as
described in the text. B, KNK437 specifically inhibits Hsp40 overexpression in Hsp40-transfected cells. 293T cells were transfected with empty vector (lane 1) or Hsp40 expression
vector treated with either vehicle control (lane 2) or KNK437 (lane 3) as described above. Cell lysates were used in immunoblotting (IB) for Hsp40, Hsp70, and Hsp90. Actin was used
as equal loading control.
FIGURE 6.Nef is required for Hsp40-induced HIV-1 LTR-mediated gene expression and virus production. A, Nef is required for Hsp40-induced LTR-mediated gene expression.
293T cells were transfected with different expression vectors along with the LTR-Luc reporter as indicated in the figure. After 4 h of transfection some of the transfected cells were
treated with 100M KNK437 for 32 h as indicated. The cells were lysed and luciferase assay was performed as described in text. B, Nef is required for Hsp40-induced increase in virus
production. Virus production was determined in culture supernatants of 293T cells transfected in the experiment in A, by using p24 antigen capture ELISA.
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tical results (data not shown), indicating that this phenomenon is not
restricted to any virus subtype.
The role of Hsp40 in LTR-mediated gene expression was further
examined by pharmacological inhibition of Hsp40 overexpression by
KNK437, a benzylidene lactamcompound, in the transfected 293T cells.
KNK437 was shown to inhibit the induction of various Hsps including
Hsp40 and Hsp70 after heat shock (46), however, it does not inhibit
basal levels of Hsp expression. Therefore, 293T cells were transiently
transfected with Hsp40 and were treated with KNK437. As shown in
Fig. 5B, the induction of Hsp40 by transient transfection was almost
completely inhibited by KNK 437, although endogenous expression of
Hsp70 and Hsp90 was not affected by this inhibitor, as they were not
induced. The HIV-1 LTR-driven gene expression observed during
Hsp40 overexpression with Tat and Nef was completely reversed in the
presence of KNK437 (Fig. 5A). KNK437 also reversed the negative effect
of Hsp40 overexpression on Tat-mediated transactivation. Put
together, all these results clearly indicate thatHsp40 specifically induces
HIV-1 LTR-driven gene expression in the presence of Nef protein.
Hsp40 Is Required for the Nef-induced Increase in Viral Gene Expres-
sion and Replication—The molecular basis of Nef-enhanced virus pro-
duction (6) is not clearly understood.Our observation thatNef interacts
with Hsp40 to augment LTR-mediated gene expression led us to inves-
tigate whether the enhanced LTR-mediated gene expression leads to
increased virus production. We then performed a single cycle replica-
tion study in 293T cells by co-transfectingHIV-1molecular clones, wild
type or nef-deleted NL4-3 along with Hsp40 and LTR-luciferase
reporter plasmid for assessing the LTR-mediated gene expression by
luciferase assay. As shown in Fig. 6A, Hsp40 induced LTR-mediated
gene expression with wild type virus but is unable to induce expression
in the case of nef-deleted virus. Co-transfection of Nef along with the
nef-deleted virus and Hsp40 restored the gene expression close to wild
type levels. An almost identical profile was obtainedwhen virus produc-
tion was analyzed by the p24 antigen assay in culture supernatants of
these cells (Fig. 6B). Thewild typeHIV-1molecular clone showed about
a 2-fold increase in viral replication with Hsp40 overexpression,
whereas there was no increase in virus production in the case of the
Nef-deletedmolecular clone, rather it was decreased (Fig. 6B). However,
putting Nef in trans with Nefminus molecular clone showed increased
virus production, which again confirms that the interaction between
Nef andHsp40 leads to an increase in LTR-mediated gene expression as
well as virus production. Furthermore, use of KNK437 in this experi-
ment along with Hsp40 co-transfection leads to reduced gene expres-
sion and decreased virus production, clearly indicating the importance
of Hsp40 and Nef interaction in the viral life cycle.
To further assess the importance of Hsp40 in virus production, the
specific siRNAduplex (Dharmacon) was used in 293T cells for silencing
HSP40 expression. As shown in Fig. 7A, expression of the HSP40 level
was significantly decreased at 72 h after SMARTpool siRNA transfec-
tion (lane 4), whereas no reduction was observed with control siRNA
(lane 1). As compared with control siRNA-transfected cells, transfec-
tion of SMARTpool Hsp40 siRNA along with the pNL4-3 molecular
clone in 293T cells showed decreased virus production (Fig. 7B). The
nef-deleted molecular clone-transfected 293T cells did not show any
significant change in p24gag antigen capture ELISA (Fig. 7B) in Hsp40-
silenced cells. An almost similar pattern was also observed at the p24
RNA level (Fig. 7C), indicating thereby that Hsp40 down-regulation in
the presence of Nef leads to decreased virus production.
Increased Translocation of Hsp40 into the Nucleus and Its Interaction
with cdk9 in HIV-1-infected Cells—Although the abovementioned data
establishes Nef-Hsp40 interaction and its role in increased gene expres-
sion and virus production, the molecular mechanism remains to be
elucidated. Because cellular stress such as heat shock mobilizes Hsp40
into the nucleus (18, 41, 42), we testedwhether stress in the form of viral
infection (13) relocates Hsp40 into the nucleus. Therefore, nuclear and
cytoplasmic extracts were prepared from HIV-1-infected and -unin-
fectedCEM-GFP cells andwas immunoblotted forHsp40. The purity of
nuclear and cytoplasmic extracts was confirmed by immunoblotting for
RNA polymerase II and actin, respectively. Hsp40 was observed in the
nucleus and cytoplasm of both uninfected and infected cells; however,
moreHsp40 was present in the nucleus of infected cells than uninfected
cells (Fig. 8A). Because Hsp40 and Nef interact with each other, we
looked at the localization of Nef in these cytoplasmic and nucleus
extracts. Our results clearly showed that Nef was also present in both
the nucleus and cytoplasm of infected cells, which correlated well with
previous reports of Nef localization in both the nucleus and cytoplasm
(30, 36, 43, 44). It has been reported that Hsp70, which is assisted by
Hsp40 for its function, is required for P-TEFb-mediated Tat transacti-
vation of viral gene expression (25). Because therewas increased nuclear
translocation of Hsp40 in infected cells, we investigated whether Hsp40
could be part of the Tat transcription complex. We performed a co-
FIGURE7.Hsp40down-regulation inhibits viral replication in thepresenceofNef.A,
HSP40 gene silencing by specific siRNA. 293T cells were transfected with 100 nM Hsp40
SMARTpool siRNA or control siRNA duplex. RT-PCRwas performed for Hsp40 expression
at different time points post-transfection. Lane 1, control siRNA (72 h); lanes 2–4, Hsp40
siRNA at 36, 48, and 72 h, respectively. B, Hsp40 down-regulation by siRNA reduces virus
production in the presence of Nef. Control or Hsp40 siRNA-transfected 293T cells as
described abovewere again transfected after 24 hwith either theNL4-3molecular clone
(lanes 1 and 2) or the Nef-deleted NL4-3 molecular clone (lanes 3 and 4). Culture super-
natants were collected at 72 h of siRNA transfection, and virus production was deter-
minedbyusingp24antigen capture ELISA.C, HIV-1p24gagexpression is down-regulated
in HSP40-silenced cells in the presence of Nef. RNA was isolated from transfected 293T
cells described above (B) after 72 h of siRNA transfection, and RT-PCRwas performed for
HIV-1 p24, HSP40, and human -ACTIN.
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immunoprecipitation experiment for Hsp40 and cdk9, using lysates
from HIV-1-infected and -uninfected CEM-GFP cells. The results in
Fig. 8B showed clearly that Hsp40 can bind to cdk9, the catalytic com-
ponent of the Tat-associated transcription complex P-TEFb. To further
confirm that Nef is part of this transcription complex, we used cdk9 and
Hsp40 immunoprecipitates of HIV-1-infected CEM-GFP cells for
immunoblottingwithNef antibody. Nef was found to be present in both
cdk9 and Hsp40 immunoprecipitates (Fig. 8C) clearly indicating its
presence in the complex. We then investigated the role of Nef in the
interaction between Hsp40 and cdk9 by co-immunoprecipitation of
293T cell lysates transfected with wild type NL4-3 or the Nef-deleted
NL4-3molecular clone usingHsp40 antibody followed by immunoblot-
ting for cdk9 (Fig. 8D). The data clearly showed that the interaction of
Hsp40 and cdk9 was Nef-dependent as Hsp40 was able to bring down
cdk9 only in the presence of Nef. These observations indicate that
Hsp40 interacts with Nef, translocates into nucleus, and integrates into
the viral transcription complex by binding to cdk9 in a Nef-dependent
manner, resulting in enhancement of LTR-mediated gene expression
and increased virus production.
DISCUSSION
In the present study, we show for the first time that Nef interacts with
one member of the heat shock protein family, Hsp40, which has been
identified by yeast two-hybrid screening and further confirmed by
immunoprecipitation and co-localization studies. This interaction is
not subtype specific as both subtypes B and C Nef bind to Hsp40. Our
data corroborates previous studies (47) suggesting that despite signifi-
cant sequence differences in the Nef from various subtypes, functional
properties remain relatively well conserved. Furthermore, our results
clearly show that Hsp40 is up-regulated in the HIV-infected cell line as
well as in infected PBMCs, and that Nef is necessary for this Hsp40
up-regulation duringHIV-1 infection. Although the role of cellular heat
shock proteins inHIV infection has been investigated by several groups,
little information has been generated about the different Hsp family
members except Hsp70. The up-regulation of Hsp70 has been reported
in HIV infection along with its presence in the virion (23, 24), however,
its role in HIV-1 infection remains to be established. Hsp70 has been
shown to interact with the Vpr protein and inhibit Vpr-induced apo-
ptosis (48). Hsp70 has also been implicated in the enhancement of the
LTR-mediated gene expression (25). Our single cycle replication studies
to identify the biological role of Nef-Hsp40 interaction further shows
that Hsp40 enhances viral gene expression and virus production specif-
ically in the presence of Nef, clearly pointing toward the importance of
this interaction. Our data clearly indicates that overexpression ofHsp40
enhances viral gene expression, whereas inhibition of Hsp40 expression
reduces viral gene expression and virus production in a Nef-dependent
manner. Furthermore, immunoblotting analyses of nuclear and cyto-
plasmic extracts from HIV-1-infected cells show increased transloca-
FIGURE 8.Hsp40 translocates into the nucleus of HIV-1-infected cells and interacts with cdk9 in aNef-dependentmanner. A, Hsp40 increases in the nucleus of HIV-1-infected
cells along with Nef. Nucleus and cytoplasm fractions were prepared from uninfected and infected CEM-GFP cells as described under “Materials and Methods.” Equal amounts of
cytoplasmic and nuclear extracts were used for immunoblotting of Hsp40 and Nef. The same blots were probed with actin and RNA polymerase II antibody as loading controls. B,
Hsp40 interactswith cdk9 inHIV-1-infected cells. CEM-GFPuninfected and infected lysateswereused for immunoprecipitationwithHsp40 antibody followedby immunoblotting (IB)
with anti-cdk9 antibody. Lysate was also subjected to immunoprecipitation with cdk9 antibody as positive control. C, Nef is a part of the Hsp40 and cdk9 complex. CEM-GFP
uninfected and -infected lysates were immunoprecipitated with either cdk9 antibody (lanes 1 and 2) or with Hsp40 antibody (lane 3) followed by immunoblotting with anti-Nef
antibody. Lysate from infected cells was used as a positive control (lane 4).D, Hsp40 interacts with cdk9 in aNef-dependentmanner. Lysates of 293T cells transfectedwith pCDNA3.1,
NL4-3molecular clone, and nef-deletedNL4-3molecular clonewere used for immunoprecipitationwithHsp40 antibody followedby immunoblottingwith anti-cdk9 antibody (lanes
1–3). Immunoprecipitation with cdk9 antibody was used as a positive control (lane 4).
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tion of Hsp40 into the nucleus of infected cells along with the presence
of Nef protein. Finally, we also show that Hsp40 interacts with cdk9 in a
Nef-dependent manner, one of the important host cell proteins
required for viral transcription, which could be the basis for Hsp40-
induced Nef-mediated enhancement of viral gene expression.
One of the early functions ascribed to Nef was that it acts as a tran-
scriptional repressor through the HIV-1 LTR, which might contribute
to viral latency (9, 26). At least two groups have failed to corroborate this
results (49, 50), whereas other groups later reported transcriptional
enhancing activity for Nef (10, 51). Nef has also been shown to activate
T cells, which increases expression of transcription factors required for
viral transcription (31). Recent reports show that Nef directly acts as a
positive modulator of HIV-1 LTR through different mechanisms (52,
53) and alsomicro-RNA for nefmay down-regulateHIV-1 transcription
(54). In our previous study (30), we have shown that Nef enhances viral
replication by interacting with its transactivator protein, Tat, and
thereby modulates viral gene expression. Both Nef and Hsp40 proteins
have been shown to be individually translocated in the nucleus by dif-
ferent groups during different conditions (18, 30, 36, 41–44). In our
previous report (30) we have also shown that Tat and Nef co-localize
more predominantly in the nucleus and enhance viral replication. Based
on the present data, it could be suggested that Tat may be involved in
bringingNef andHsp40 proteins into the nucleus, as the ability of intra-
cellular trafficking by Tat is well documented and a specific region of
Tat is actually used in intracellular delivery of proteins (55–57). Alter-
natively the role of Hsp40 in chaperoning Nef inside the nucleus may
not be ruled out.
The present study provides further insight into the molecular mech-
anism of the Nef-induced enhancement of viral gene expression and
replication. In summary, we conclude that Nef not only interacts with
Hsp40 but also up-regulates the expression of Hsp40 in HIV infection.
Nef andHsp40 interaction leads to enhancement of LTR-mediated gene
expression and virus production. All our data clearly shows that Hsp40
enhances viral gene expression and replication in a Nef-dependent
manner. It is worthmentioning here that similar phenomena have been
observed in avian adenovirus CELO, where the viral protein Gam1 acti-
vates Hsp40 and thereby induces viral replication (58). Finally, interac-
tion of Hsp40 with cdk9, the catalytic component of P-TEFb, suggests
that the Nef-Hsp40 complex could be part of the viral transcription
assembly. All together our findings lead us to hypothesize a model in
infected cells, where Nef is responsible for Hsp40 up-regulation fol-
lowed by Nef-Hsp40 interaction. This interaction then may lead to
increased translocation of Hsp40 into the nucleus of infected cells along
with Nef and Tat where Hsp40 binds to cdk9 and enhances viral repli-
cation by modulating the activity of P-TEFb. Finally, the present work
not only provides a molecular basis of Nef-mediated enhancement of
viral gene expression and replication but also identifies a novel viral
strategy to use cellular heat shock response proteins to its own
advantage.
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